MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma.

Technol Cancer Res Treat · 2021 · PMC8591776 · PMID 34761715

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the GSE53625 cohort, patients with lower MXD1 expression were associated with a more aggressive TNM stage, although the difference did not reach statistical significance ( Figure 1B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.